Werewolf Therapeutics share price logo

Werewolf Therapeutics

NASDAQ: HOWL

$0.98

+0.02

(+1.64%)

as on

Werewolf Therapeutics Stock Performance

as on September 19, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.96
    $1.01
    downward going graph

    1.92%

    Downside

    3.19%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.27
    $2.38
    downward going graph

    72.42%

    Downside

    143.15%

    Upside

    downward going graph

Werewolf Therapeutics share price movements today

Previous Close
$0.96
Open
$0.97
Volume
1.2M
Market Cap
$44.7M
Day's Low - High
$0.96 - $1.01
52 Week Low - High
$0.27 - $2.38

Werewolf Therapeutics Historical Returns

1 Month Return
+ 135.28 %
3 Month Return
+ 174.12 %
1 Year Return
-35.37 %
3 Year Return
-62.09 %
5 Year Return
-94.57 %

Werewolf Therapeutics Stock Fundamentals & Key Indicators

Check Werewolf Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$44.7M

EPS (TTM)

-0.7345

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.33

Industry PE ratio

-2.37

PEG Ratio

-0.016327186108389027

EBITDA

-22.0M

Revenue (TTM)

21.0M

Profit Margin

86.43%

Return On Equity TTM

-166.98%

Werewolf Therapeutics Stock Valuation

Track how Werewolf Therapeutics P/E has moved over time to understand its valuation trends.

Werewolf Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-4.40x)

December 31, 2021

Industry (-2.37x)

December 31, 2025

Today (-0.48x)

December 31, 2025

Highest (-0.48x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.48x

Werewolf Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Werewolf Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Werewolf Therapeutics image
Werewolf Therapeutics
BUY$44.7M-94.57%-1.3386.43%0.00%
Moderna image
Moderna
BUY$63.1B-63.24%-19.81-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$130.1B174.21%29.8186.04%0.00%
Regeneron image
Regeneron
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Werewolf Therapeutics Stock including INR - Dollar returns

The Werewolf Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Werewolf Therapeutics investment value today

Current value as on today

₹71,401

Returns

-₹28,599

(-28.6%)

Returns from Werewolf Therapeutics Stock

-₹34,309 (-34.31%)

Dollar Impact

₹5,710 (+5.71%)

Analyst Recommendation on Werewolf Therapeutics Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Werewolf Therapeutics. Average target price of $7

Werewolf Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Werewolf Therapeutics.

What analysts predicted

86.02%UPSIDE

Target Price

$7

Current Price

$0.9788

Analyzed by

12 Analysts

Target

$7.00

Werewolf Therapeutics target price $7, a slight upside of 86.02% compared to current price of $0.9788. According to 12 analysts rating.

Indian Investors' Interest in Werewolf Therapeutics Stock

Investment in Werewolf Therapeutics Shares on INDmoney has grown by 1161.90% in the last 30 days, indicating increased investment activity.

Time period: to

Change:1161.90% versus previous 30 day period

Search interest for Werewolf Therapeutics Stock has increased by 779% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:779% versus previous 30 day period

Werewolf Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
1
-
-
-
-
-
-
-
21
Gross Profit
0
0
-
-
0
0
-
-
0
18
Operating Income
-17
-18
-17
-20
-17
-17
-15
-9
-8
8
EBITDA
-14
-15
-14
-18
-16
-16
-14
-6
-11
10
Interest Expense
1
1
1
1
1
1
1
1
1
0
Depreciation
0
0
0
0
0
0
0
0
0
2
Income Before Tax
-16
-17
-16
-20
-18
-17
-16
-8
-13
3
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-16
-17
-16
-20
-18
-17
-16
-8
-13
3
Net Profit Margin
37.47%
60.28%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
88.32%

Werewolf Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
16
19
1
-
Gross Profit
0
0
-
13
18
0
-1
Operating Income
-9
-22
-50
-56
-40
-73
-60
EBITDA
-9
-14
-49
-51
-32
-64
-53
Interest Expense
0
-
-
-
3
4
5
Depreciation
0
0
0
2
1
1
1
Income Before Tax
-10
-15
-49
-53
-37
-70
-60
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-10
-14
-49
-53
-37
-70
-60
Net Profit Margin
0.00%
0.00%
0.00%
84.70%
91.15%
3.77%
0.00%

Werewolf Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-16
-17
-16
-20
-18
-17
-16
-8
-13
3
Operating Cash Flow
-15
-14
-12
-14
-18
-15
-15
-11
-10
6
Investing Cash Flow
0
0
0
0
-
-
-
-
-
0
Financing Cash Flow
20
-9
0
2
-
0
3
2
-
-32
Change in Cash
4
-23
-12
-11
-18
-14
-11
-8
-10
-24

Werewolf Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-10
-15
-49
-53
-37
-70
-60
Operating Cash Flow
-9
-18
-42
-40
-32
-56
-60
Investing Cash Flow
0
0
0
-3
0
0
-
Financing Cash Flow
21
93
109
15
58
13
6
Change in Cash
12
74
66
-28
25
-43
-54

Mutual Funds that own Werewolf Therapeutics Stock

Check out the Mutual Funds with significant holdings in Werewolf Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.506171%
1217976
Fidelity Concord Street Trust
0.570317%
277169
Bridgeway Funds, Inc.
0.154323%
75000
Victory Portfolios III
0.004463%
2169
ProFunds
0.00089%
433

Global Institutional Holdings in Werewolf Therapeutics

Funds
Holdings
Peter Kolchinsky
4.91%
Vanguard
2.51%

Insights on Werewolf Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -13.53M → 3.67M (in $), with an average increase of 468.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, HOWL stock has moved up by 135.3%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -49.0K → 20.99M (in $), with an average increase of 100.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 521.1% return, outperforming this stock by 554.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 51.8% return, outperforming this stock by 112.3%

About Werewolf Therapeutics

Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. In addition, it develops WTX-1011, a conditionally activated INDUCER T cell engager molecule that targets STEAP 1 for prostate cancer, as well as WTX-2022 that targets CDH6 for ovarian and kidney cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.
OrganisationWerewolf Therapeutics
Headquarters200 Talcott Ave, Watertown, MA, United States, 02472
IndustryBiotechnology
CEODr. Daniel J. Hicklin Ph.D.
E-voting on sharesClick here to vote

Key Management of Werewolf Therapeutics

Name

Title

Mr. Michael J. Urban

VP of Finance, Corporate Controller & Principal Financial Officer

Mr. Jonathan Owen

Senior VP, General Counsel & Secretary

Dr. Daniel J. Hicklin Ph.D.

Founder, CEO, President & Director

FAQs

What is Werewolf Therapeutics share price today?

Werewolf Therapeutics share price today is $0.98 as on at the close of the market. Werewolf Therapeutics share today touched a day high of $1.01 and a low of $0.96.

What is the 52 week high and 52 week low for Werewolf Therapeutics share?

Werewolf Therapeutics share touched a 52 week high of $2.38 on and a 52 week low of $0.27 on . Werewolf Therapeutics stock price today i.e. is closed at $0.98,which is 58.87% down from its 52 week high and 262.52% up from its 52 week low.

What is Werewolf Therapeutics's market capitalisation today?

Werewolf Therapeutics market capitalisation is $0.00T as on .

How to invest in Werewolf Therapeutics Stock (HOWL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Werewolf Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Werewolf Therapeutics Shares that will get you 1.5325 shares as per Werewolf Therapeutics share price of $0.98 per share as on September 19, 2026 at 1:29 am IST.

What is the minimum amount required to buy Werewolf Therapeutics Stock (HOWL) from India?

Indian investors can start investing in Werewolf Therapeutics (HOWL) shares with as little as ₹95.8725 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.73 in Werewolf Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Werewolf Therapeutics share’s latest price of $0.98 as on September 19, 2026 at 1:29 am IST, you will get 10.2166 shares of Werewolf Therapeutics. Learn more about fractional shares .

What are the returns that Werewolf Therapeutics has given to Indian investors in the last 5 years?

Werewolf Therapeutics stock has given -94.57% share price returns and 30.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?